Tennessee House Bill HB0913

Tennessee 2023-2024 Regular Session

• Introduced: 1/30/23
• Refer: 2/2/23

Caption

AN ACT to amend Tennessee Code Annotated, Title 39; Title 53 and Title 63, relative to prescription drugs.

Impact

This bill is expected to have a significant impact on state laws concerning prescription drugs, specifically by formalizing a process that healthcare providers must follow when prescribing opioids. The legislation aims to enhance patient awareness of the risks linked to opioid use and potentially mitigate the ongoing crisis related to addiction and overdoses. By requiring documentation of these discussions in medical records, the bill emphasizes accountability among practitioners and promotes safer prescribing practices.

Summary

House Bill 0913 aims to amend Tennessee law regarding the prescription of opioids and other controlled substances. It mandates that prior to issuing an initial prescription for a Schedule II controlled substance or another opioid prescription pain reliever, healthcare practitioners must discuss associated risks with patients, including the dangers of addiction, overdose, and potential dependence. This requirement extends to repeated prescriptions, highlighting the need for ongoing patient education about the risks and alternative treatments available.

Sentiment

General sentiment around HB 0913 appears to be supportive of the intent to address opioid addiction and enhance patient education. Many stakeholders recognize the increasing need for rigorous guidelines surrounding opioid prescriptions due to public health concerns. This sentiment aligns with broader national efforts to combat the opioid crisis, reflecting a growing awareness and proactive stance among legislators and health professionals on the importance of patient safety.

Contention

While there is broad support for the goals of HB 0913, potential points of contention arise regarding the practicality of implementation. Some practitioners may express concern about the added burdens this bill places on their workflow, especially regarding documentation requirements and the need for thorough discussions with each patient. Additionally, some stakeholders may argue that this approach could impact timely access to necessary pain relief for patients, particularly those with chronic conditions, thus sparking a debate over balancing patient care with the need for prudent prescribing.